Johnson & Johnson Launches Heartline™, the First-of-Its-Kind, Virtual Study Designed to Explore if a New App can Help Reduce Stroke Risk

Johnson & Johnson has announced that the Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Apple, opened enrollment for the Heartline Study. The study is designed to explore if the Heartline Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the risk of stroke, with earlier detection of atrial fibrillation (AFib). AFib, a common form of irregular heart rhythm, is a leading cause of stroke in the U.S. To enroll in the Heartline Study, individuals must be age 65 or…

Read More

On World Stroke Day, Stryker reminds the public to act FAST when witnessing signs of stroke

For World Stroke Day, Medical Company Stryker launches campaign to highlight the importance of recognizing the signs of stroke and seeking treatment quickly. Stroke is a major cause of mortality worldwide, resulting in six million deaths each year, and leaving another five million permanently disabled. Approximately 1.9 million neurons are lost every minute during a stroke, making the recognition of warning signs essential to receiving timely treatment and reducing the risk of long-term effects. Stroke requires FAST action There are some common signs of a stroke, known as “FAST,” or…

Read More